Prestige®ii With Havlogen

Prestige® II with Havlogen, 1 dose vial SKU: 060INV11-1 [printable] Intervet Equine Rhinopneumonitis - Influenza VaccineKilled Virus U.S. Veterinary License No. 286 A combination of inactivated, purified, concentrated, adjuvanted, tissue culture origin Equine Herpesviruses EHV-1 and EHV-4 and Equine Influenza Virus subtype A2, including KY93 strain. Intervet serological data suggest Influenza cross protection against certain U.S. and European strains, including Kentucky 93, 94, 95 and 96, Suffolk 89, Kildare 89 and 92, Austria 92, Switzerland 93, New Market 1/93 and 2/93, Berlin 94, Italy 96 and Meath 96. Indications: For vaccination of healthy horses as an aid in the prevention of respiratory disease caused by Equine Influenza Virus and as an aid in the control of respiratory disease caused by Equine Herpesvirus. Dose: For primary immunization, aseptically inject 1 mL intramuscularly and repeat the dose in 3 to 4 weeks. A 1 mL dose should be administered annually and at any time epidemic conditions exist or are reported and exposure is imminent. Cautions: Store at 35° to 45°F (2° to 7°C). Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactoid reactions may occur. Caution: Needle is sharp and may cause injury to self or animals if not handled properly or disposed of properly. Antidote: Epinephrine. Gentamicin and thimerosal added as preservatives.*Adjuvant-Intervet's Proprietary Technology. For Use In Animals Only Horse Products>Vaccines